Business DevelopmentThere is a significant number of new deals in the pipeline, including municipality, hospital, and payer or provider deals.
Company ProspectsAnalyst reiterates a Buy rating on DocGo, suggesting confidence in the company's prospects despite recent challenges.
Revenue Guidance2025 revenue guidance was re-affirmed, indicating confidence in achieving future goals.